Infertility - discovery could mean new treatment

A team of Japanese scientists at Osaka University led by Dr Masaru Okabe have discovered a protein essential for human sperm to fuse to an egg. The findings could well lead to new methods of treating infertility and the development of new contraceptive strategies.

The protein, Izumo, is named after a Japanese shrine dedicated to marriage. Human sperm has a number of obstacles to overcome in it's Herculian race to fertilise the egg. It must pass through a barrier of follicle cells surrounding the freshly ovulated egg. It then has to penetrate the egg's outer wall, the zona pellucida, a thick layer that protects the egg, so that it can bind to the plasma membrane beyond it.

The team bred male mice genetically engineered to lack the Izumo protein which were found to be infertile. In laboratory tests mouse sperm which did not have the protein were unable to fuse with the egg. The sperm from the mice was able to penetrate both of the barriers around the egg, but not one Izumo-deficient sperm was seen to fuse with the egg membrane. They have discovered that a form of the Izumo protein also exists on human sperm. Tests showed that an antibody designed to react against the protein blocked the fusion of human sperm with hamster eggs, which is a recognised test for male fertility.

Writing in Nature, Dr Masaru Okabe, said "Our finding not only provides insight into the enigmatic fusion mechanism (of the egg and the sperm), but also promises benefits in the clinical treatment of infertility and the potential development of new contraceptive strategies."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH funds study to explore infertility and health issues among Hispanic women of Mexican heritage